Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03768206 · ClinicalTrials.gov registry record · NA
The PATH Study to Promote Physical Activity After Knee Replacement
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03768206: Completed NA study, sponsored by University of South Carolina.
NCT03768206 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03768206, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the feasibility and preliminary efficacy of a physical therapist led physical activity intervention for knee replacement patients within an outpatient physical therapy facility.
Primary Outcome
Feasibility will be determined based on the number of participants enrolled vs. the number approached
Interventions
- BEHAVIORAL Standard Physical Therapy
- BEHAVIORAL Physical therapist discuss aerobic physical activity
- BEHAVIORAL Physical activity session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-01-14 |
| Est. Completion | 2020-06-15 |
| Phase | NA |
What the finished NCT03768206 record still lists
NCT03768206 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard Physical Therapy is the first listed.
NCT03768206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03768206 about?
NCT03768206 is a clinical study titled "The PATH Study to Promote Physical Activity After Knee Replacement". The purpose of this study is to examine the feasibility and preliminary efficacy of a physical therapist led physical activity intervention for knee replacement patients within an outpatient physical therapy facility.
What is the current status of trial NCT03768206?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-01-14. Estimated completion is 2020-06-15.
What interventions are being tested in trial NCT03768206?
The interventions under investigation include: Standard Physical Therapy (BEHAVIORAL), Physical therapist discuss aerobic physical activity (BEHAVIORAL), Physical activity session (BEHAVIORAL).
Who is sponsoring clinical trial NCT03768206?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03768206's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI